Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial [version 3; peer review: 2 approved]
Journal article published in 2019 by
Nicola McMeekin,
Claudia Geue,
Andrew Briggs,
Ines Rombach,
Ho Kwong Li,
Philip Bejon,
Martin McNally 
,
Bridget L. Atkins,
Jamie Ferguson,
Matthew Scarborough,
Collaborators Oviva
,
Bridget L. Atkins,
Jamie Ferguson,
Matthew Scarborough,
Collaborators Oviva
